Exousia Bio (LMMY) Accumulated Expenses (2022 - 2024)
Exousia Bio (LMMY) posted Accumulated Expenses of $1211.0 for Q3 2024, little changed sequentially from $1211.0 in Q2 2024, and down 72.16% YoY from $4350.0 in Q3 2023.
Analysis
Exousia Bio (LMMY) Accumulated Expenses (2022 - 2024) Analysis & Trends
Exousia Bio (LMMY) has 2 years of Accumulated Expenses data on file, last reported at $1211.0 in Q3 2024.
- Quarterly Accumulated Expenses fell 72.16% year-over-year to $1211.0 in Q3 2024, while the trailing twelve-month figure through Aug 2024 was $1211.0 (down 72.16% YoY) and the FY2024 annual result came in at $1211.0, up 98.52% from the prior year.
- Accumulated Expenses held at $1211.0 in Q3 2024 per LMMY's latest filing, from $1211.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $5972.0 in Q1 2024, with the low at $610.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | New Oriental Education & Technology | 94.81 Bn | 92.07 Bn | 812.22 Mn |
| 2 | Laureate Education | 5.12 Bn | 4.96 Bn | 237.67 Mn |
| 3 | Graham Holdings | 4.84 Bn | 3.59 Bn | 777.03 Mn |
| 4 | Covista | 4.55 Bn | 4.14 Bn | 284.63 Mn |
| 5 | Grand Canyon Education | 3.99 Bn | 3.72 Bn | 204.08 Mn |
| 6 | Stride | 3.71 Bn | 2.75 Bn | 217.28 Mn |
| 7 | McGraw Hill | 2.54 Bn | 2.34 Bn | 439.20 Mn |
| 8 | Perdoceo Education | 2.10 Bn | 797.06 Mn | 162.46 Mn |
| 9 | TAL Education | 1.94 Bn | -740.46 Mn | 227.32 Mn |
| 10 | Exousia Bio | 368,824.87 | 368,824.87 | -62,108.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2024 | 12,495.00 |
| May 31, 2024 | 11,079.00 |
| Feb 29, 2024 | 5,972.00 |
| Nov 30, 2023 | 8,250.00 |
| Aug 31, 2023 | 4,350.00 |
| May 31, 2023 | 5,422.00 |
| Feb 28, 2023 | 4,011.00 |
| May 31, 2022 | 333.00 |